E. Ohman J or Asset Management AB Purchases 1,130 Shares of HCA Healthcare, Inc. (NYSE:HCA)

E. Ohman J or Asset Management AB raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,030 shares of the company’s stock after purchasing an additional 1,130 shares during the period. E. Ohman J or Asset Management AB’s holdings in HCA Healthcare were worth $2,710,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. FMR LLC grew its position in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Meritage Group LP bought a new position in HCA Healthcare in the 3rd quarter valued at approximately $150,548,000. Canoe Financial LP increased its holdings in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after buying an additional 231,492 shares in the last quarter. Holocene Advisors LP boosted its holdings in shares of HCA Healthcare by 210.6% during the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after acquiring an additional 208,015 shares in the last quarter. Finally, Nordea Investment Management AB increased its holdings in HCA Healthcare by 29.7% in the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after purchasing an additional 193,075 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.3 %

HCA stock opened at $335.31 on Wednesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock’s 50 day simple moving average is $313.52 and its 200 day simple moving average is $353.59. The company has a market cap of $84.93 billion, a P/E ratio of 15.26, a price-to-earnings-growth ratio of 1.13 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm posted $5.90 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 24.89 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on HCA shares. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Royal Bank of Canada dropped their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. KeyCorp reduced their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.